Obesity rates are rising due to changes in the environment, particularly the rise of ultra-processed foods. These foods are designed to be highly palatable, hitting the 'bliss point' and triggering dopamine responses, making them addictive. This obesogenic environment has replaced traditional diets in many countries, contributing to weight gain.
In countries like Australia and New Zealand, about half of the diet consists of ultra-processed foods. In the U.S., it's around 60%.
Weight-loss drugs like Ozempic are gaining acceptance because they have shown significant effectiveness in helping people lose weight, especially those with great need. The evidence supporting their use has been strong, despite initial skepticism.
AI is currently being used in healthcare for tasks like triaging chest X-rays and medical transcription. In radiology, AI helps prioritize urgent cases, while in general practice, it assists with taking clinical notes during patient consultations.
AI faces challenges in healthcare, especially with transcription, due to issues like inaccuracies in understanding accents and similar-sounding medical terms. These errors can lead to misdiagnosis or incorrect treatment plans if not carefully monitored by doctors.
The food industry plays a significant role by producing ultra-processed foods that are highly palatable, addictive, and marketed heavily. These foods have taken over traditional diets, contributing to overconsumption and rising obesity rates globally.
The Sydney hailstorm of 1999 was a transformative event for the State Emergency Service (SES). It highlighted the need for better communication systems, centralised call centres, and improved public messaging. The SES also upgraded its technology and response capabilities in the aftermath.
The 1999 Sydney hailstorm caused $1.7 billion in damage at the time, which is equivalent to $8.85 billion in today's dollars.
GLP-1 agonist drugs like Ozempic have potential long-term effects beyond weight loss, including reducing heart disease and kidney disease risks. They may also be used for other conditions, such as diabetes, due to their multiple effects on the body.
Obesity is considered a disease because it affects individuals internally and can be treated with medications, but it is also a public health problem due to its societal and environmental causes. Labeling it as a disease helps individuals feel it is not solely their fault, while addressing it as a public health issue requires broader interventions.
Once considered a problem for high-income countries, being overweight is now on the rise in low- and middle-income parts of the world. At least 2.5 billion adults are now overweight or obese.
What’s causing this collective weight gain?
And if 2023 was the year of hype about weight-loss drugs like Ozempic, 2024 felt like the year of acceptance. We find out why weight-loss drugs are here to stay.
This week we’re joined by health journalist and Radio National presenter Tegan Taylor.